Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Merrimack Pharmaceuticals)"
Count: 29
Selected: 0
NCT03076372A Study Evaluating MM-310 in Patients With Solid Tumors
NCT02785068Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer
NCT02538627Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib
NCT02399137A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer
NCT02213744MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients
NCT01774851A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach
NCT01733004A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
NCT01520389Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
NCT01494506Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
NCT01451632A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
NCT01447706A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
NCT01447225Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
NCT01421472A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer
NCT01304797Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
NCT01304784A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer
NCT01209195A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers
NCT01151046Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
NCT01097460MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
NCT00994123A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
NCT00911898A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers
NCT00734305Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
NCT00458146A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis
NCT00444743Phase 2 Study of MM-093 to Treat Patients With Uveitis
NCT00147329Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis
NCT00105976Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)
NCT02640365A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer
NCT02387216A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
NCT01436565A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers
NCT03119064BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma